Checkpoint Therapeutics’ (CKPT) Hold Rating Reaffirmed at Lake Street Capital
Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report)‘s stock had its “hold” rating reiterated by equities research analysts at Lake Street Capital in a research report issued on Monday,Benzinga reports. They presently have a $4.10 price objective on the stock, down from their prior price objective of $7.00. Lake Street Capital’s price objective would indicate a […]
Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report)‘s stock had its “hold” rating reiterated by equities research analysts at Lake Street Capital in a research report issued on Monday,Benzinga reports. They presently have a $4.10 price objective on the stock, down from their prior price objective of $7.00. Lake Street Capital’s price objective would indicate a […]
